Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Stability of Medicines and Novel Approaches for Predicting Drug Stability (Deadline: 10 November 2024)
- Advanced Spectroscopic Techniques and Amorphous Systems in Pharmaceutical Formulation (Deadline: 20 November 2024)
- Hypromellose in Modern Pharmaceutics: From Advanced Drug Delivery to Process Optimization and Quality Control (Deadline: 20 November 2024)
- Natural Innovations in Pharmaceutical Formulation: From Traditional Remedies to Modern Drug Carriers (Deadline: 20 November 2024)
- Polymer- and Lipid-Based Nanostructured Drug Delivery Systems for the Treatment of CNS Diseases: Recent Advances towards Clinical Application, 2nd Edition (Deadline: 20 November 2024)
- New Drug Formulations for Chagas's Disease Treatment (Deadline: 30 November 2024)
- From Bench to Bedside: Integrating Patient-Centric Design in Lipid-Based Drug Formulations (Deadline: 30 November 2024)
- Pharmaceuticals Based on or Loaded with Natural Products (Deadline: 30 November 2024)
- Development of Spray-Dried Powders for Pulmonary Drug Delivery (Deadline: 30 November 2024)
- Biopolymers for Biomedical and Pharmaceutical Applications (Deadline: 10 December 2024)
- Pharmaceutical Formulation of Novel Bioactive Molecules from Marine Sources (Deadline: 10 December 2024)
- Microemulsion Utility in Pharmaceuticals (Deadline: 20 December 2024)
- Novel Dry Powder Formulation and Delivery Systems (Deadline: 20 December 2024)
- Advance in Development of Patient-Centric Dosage Form, 3rd Edition (Deadline: 20 December 2024)
- Advances in Parenteral Formulations (Deadline: 20 December 2024)
- Aspects and Implementation of Pharmaceutical Quality by Design, 2nd Edition (Deadline: 31 December 2024)
- Controlled Crystallization of Active Pharmaceutical Ingredients, 2nd Edition (Deadline: 31 December 2024)
- Pharmaceutical Polymorphs and Cocrystals and Their In Vitro and In Vivo Evaluation (Deadline: 31 December 2024)
- Mucosal Drug Delivery: Exploring Novel Approaches and Formulations (Deadline: 31 December 2024)
- New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System (Deadline: 31 December 2024)
- Antimicrobial Resistance and Antimicrobial Activity of Bioactive Compounds in Drug Formulations (Deadline: 31 December 2024)
- A Commemorative Issue in Honor of Professor Gregory Gregoriadis: Liposomes for the Delivery of Drugs and Vaccines (Deadline: 31 December 2024)
- Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals (Deadline: 31 December 2024)
- Biofunctional Pharmaceutical Additives for Targeted, Improved Bioavailability and Safety of Medicine (Deadline: 31 December 2024)
- Recent Progress in Solid Dispersion Technology, 3rd Edition (Deadline: 10 January 2025)
- Pharmaceutical Solid Forms: From Crystal Structure to Formulation (Deadline: 20 January 2025)
- Recent Advances in Oral Pharmaceutical Forms (Deadline: 20 January 2025)
- Advanced Pediatric Drug Formulation Strategies (Deadline: 20 January 2025)
- Physical and Chemical Stability of Drug Formulation (Deadline: 25 January 2025)
- Advances in Inhaled Formulations for Pulmonary Drug Delivery (Deadline: 31 January 2025)
- New Perspectives for the Administration of Cannabis for Medical Use: From Traditional to Advanced Formulations. What Next? (Deadline: 31 January 2025)
- Impact of Raw Material Properties on Solid Dosage Form Processes (Deadline: 31 January 2025)
- Dosage Form Design and Delivery Therapy for Skin Disorders (Deadline: 20 February 2025)
- Drug Polymorphism and Dosage Form Design, 2nd Edition (Deadline: 20 February 2025)
- New Approach to Anti-inflammation, Antibacterial and Anti-cancer Therapy: Natural Extracts (Deadline: 20 February 2025)
- Antimicrobial Agents Based on Nanomaterials (Deadline: 20 February 2025)
- Natural Product Pharmaceuticals (Deadline: 20 February 2025)
- Advances in Analysis and Modeling of Solid Drug Product (Deadline: 20 March 2025)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages, 2nd Edition (Deadline: 25 March 2025)
- Preparation and Development of Amorphous Solid Dispersions (Deadline: 31 March 2025)
- Improving the Bioavailability and Solubility of Pharmaceutical Formulations (Deadline: 31 March 2025)
- Biocompatibility and Antimicrobial Studies of Pharmaceutical Formulations (Deadline: 31 March 2025)
- Regenerative Biomaterials with Plant Derivatives for Skin Wound Therapy (Deadline: 31 March 2025)
- Drug Formulations Based on Chitosan and Its Derivatives for Therapeutic Applications (Deadline: 20 April 2025)
- Establishment Tips and Development Strategies for Innovative Pharmaceutical Formulation Products (Deadline: 20 April 2025)
- Bioactive Hydrogels as Multifunctional Dressing Materials (Deadline: 20 April 2025)
- Application of Marine-Derived Polymers in Drug Dosage Forms (Deadline: 20 April 2025)
- Exploring the Versatility of Cyclodextrins in Pharmaceutical Formulations (Deadline: 30 April 2025)
- Phytocompounds-Based Formulations for Anti-Inflammatory Disorders (Deadline: 10 May 2025)
- Exploring Solid Dosage Forms: Characterization, Dissolution, and Stability (Deadline: 30 May 2025)
- Recent Advances in Nanococrystal Formulation Technology for Pharmaceutical and Nutraceutical Applications (Deadline: 30 June 2025)
- Formulation Design of Lipid Nanoparticles for Pharmaceutical Applications (Deadline: 30 June 2025)
- Pharmaceutical Excipients: Impact on Efficiency, Stability, and Solubility in Formulation (Deadline: 31 July 2025)
- Development and Evaluation of Inhalable Dry Powder Formulations, 2nd Edition (Deadline: 31 August 2025)
- Development and Optimization of Buccal Films Formulations (Deadline: 31 August 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
